H

Humedix Co Ltd
KOSDAQ:200670

Watchlist Manager
Humedix Co Ltd
KOSDAQ:200670
Watchlist
Price: 45 250 KRW 7.74% Market Closed
Market Cap: 466.5B KRW
Have any thoughts about
Humedix Co Ltd?
Write Note

Humedix Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Humedix Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
H
Humedix Co Ltd
KOSDAQ:200670
Operating Income
â‚©38.2B
CAGR 3-Years
41%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Operating Income
â‚©72.6B
CAGR 3-Years
-5%
CAGR 5-Years
44%
CAGR 10-Years
0%
SK Biopharmaceuticals Co Ltd
KRX:326030
Operating Income
-â‚©37.5B
CAGR 3-Years
46%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Operating Income
â‚©255.8B
CAGR 3-Years
27%
CAGR 5-Years
23%
CAGR 10-Years
19%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Operating Income
â‚©4.2B
CAGR 3-Years
N/A
CAGR 5-Years
-28%
CAGR 10-Years
-14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Operating Income
â‚©29.3B
CAGR 3-Years
-15%
CAGR 5-Years
24%
CAGR 10-Years
15%
No Stocks Found

Humedix Co Ltd
Glance View

Market Cap
470.4B KRW
Industry
Pharmaceuticals

Humedix Co., Ltd. engages in the manufacture and sale of hyaluronic acid based medical devices and arthritis treatment products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2014-12-26. The firm distributes its products within domestic market and to overseas markets

Intrinsic Value
63 381.73 KRW
Undervaluation 29%
Intrinsic Value
Price
H

See Also

What is Humedix Co Ltd's Operating Income?
Operating Income
38.2B KRW

Based on the financial report for Sep 30, 2024, Humedix Co Ltd's Operating Income amounts to 38.2B KRW.

What is Humedix Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
30%

Over the last year, the Operating Income growth was 29%. The average annual Operating Income growth rates for Humedix Co Ltd have been 41% over the past three years , 30% over the past five years .

Back to Top